Integrium is a full-service Clinical Research Organization (CRO) exclusively dedicated to the management of cardiovascular and metabolic disease clinical trials. We combine our focused clinical expertise with strong operational capabilities to deliver the highest level of customer care. Within our singular therapeutic focus, our vast trial experience spans across all stages of clinical development and stretches around the globe, from single region, proof-of-concept studies to multinational pivotal trials with more than 6,000 subjects.

The impressive operational capacity and depth of experience of Integrium is a product of our years spent conducting landmark clinical trials on behalf of our sponsors. With a customer list of pharmaceutical, biopharmaceutical, and medical device companies that would be the envy of many companies larger in size, Integrium has efficiently integrated our operations with a wide array of clients.

Founded and guided by thought leaders in cardiovascular and metabolic disease research, Integrium has a distinct advantage when designing and executing cardiovascular and metabolic disease clinical trials. The clinical expertise of our founders and staff, as well as to our network of high-enrolling investigators, has resulted in a proven track record of success.

In addition to our valuable strategic clinical insight and operational excellence, Integrium also provides clients with unparalleled service. Integrium is deeply committed to our clients’ satisfaction throughout the various stages of the clinical trial process. We believe that every client deserves responsive, attentive service—regardless of their size. We therefore pride ourselves on the delivery of that extra attention. 

So whether you are a startup biotechnology or a major pharmaceutical company or any company in between, Integrium wants to provide value to your next clinical study. By forging a partnership that seamlessly integrates our processes with yours, we can help reach common goals while ensuring you receive the attention you deserve.  

We look forward to helping you achieve success in your next cardiovascular or metabolic disease clinical trial. 

Integrium Introductory Overview Document